2型高喘治疗的进步:还缺少什么?
Ahmad Z Al Meslamani1, Anan S Jarab2, Abdullah Elrefae3
1College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
Expert review of respiratory medicine
|October 1, 2025
概括
2型高喘 (T2HA) 治疗面临挑战. 尽管有生物药物,但许多患者仍然表现出症状,这凸显了需要更好的获取,成本效益和用于严重喘管理的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 卫生经济学 卫生经济学
背景情况:
- 2型高喘 (T2HA) 是一种严重的炎症状况.
- 目前的生物药物为许多患者提供有限的解决方案,这些患者仍然有症状或依赖皮质类固醇.
- 高昂的成本造成了对先进的T2HA疗法的接入障碍.
研究的目的:
- 综合现有和新兴T2HA干预措施的证据.
- 评估药物开发后期阶段的局限性,生物耐用性和小分子进步.
- 确定成本获取障碍,并探索未来的治疗和经济策略.
主要方法:
- 从2005年1月到2025年6月,在多个数据库 (PubMed,Embase,Web of Science,Scopus,Cochrane Library,EconLit,ClinicalTrials.gov,WHO-ICTRP) 中进行了全面的文献搜索.
- 从随机试验,经济评估和翻译研究中综合证据.
- 分析侧重于生物制剂,小分子,基于细胞和微生物组的干预措施,检查磨损,耐用性和成本.
主要成果:
- 以表型为指导的生物药物已经推进了T2HA治疗,但在有效性和不确定的长期安全性方面面临高原.
- 对T2HA的小分子药物的进展缓慢,成本和获取障碍显著.
- 超长效生物药物显示出潜力,但需要进一步评估耐用性和儿科数据.
结论:
- 未来的T2HA管理需要基于价值的定价,适应性临床试验和组合疗法.
- 可持续和公平的T2HA护理需要综合科学,监管和经济方法.
- 超越狭窄的细胞因子标对于全面解决T2HA至关重要.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:24Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K